XAIR - beyondair.net Debt to Book Capitalization Ratio

Corporate company logo of AINostix (XAIR)

Beyond Air, Inc. (XAIR) stability is based on a strong staff of biomedical experts and unique patents. Monetization relies on the premium pricing of compact nitric oxide generators, although a cash gap necessitates the acquisition of loans. The ratio of debt obligations to balance sheet capital clearly demonstrates borrowing dynamics, where 11.20 determines this parameter level.

Beyond Air Inc - XAIR Debts to Book Capitalization (period 07/04/2022 - 10/28/2026)
Flagship merchandise of Beyond Air Inc

Investors seek a balance between asset value and debt load. This indicator measures the proportion of liabilities within the balance sheet capital structure, accounting for the daily volatility of the issuer's market valuation. For Beyond Air, Inc. (XAIR), this calculation reflects financial stability while scaling the production of innovative nitric oxide generators. Effective debt management ensures the expansion of medical systems without sacrificing liquidity. Analyze the ratio of borrowed funds to balance sheet capitalization to assess default risks.

Competitors of Beyond Air, Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio